DISCOVERY SERVICES: CHEMRX

ChemRx, a subsidiary of Discovery Partners International Inc. (DPII), offers its services for drug discovery.

ChemRx Chemistry services include:

• Discovery library synthesis to research and design novel scaffolds.
• Targeted library synthesis to find hits for specific targets.
• Focused library synthesis to to advance hits to leads.
• Lead optimization synthesis to provide the most efficient compound synthesis.
• Custom library synthesis according to specific needs.

ChemRx Chemistry products include:

• Compound libraries.
• Discovery libraries (4,000 to 6,000 compounds per scaffold, purities >90%).
• Targeted libraries ( kinases, proteases, phosphatases, GPCRs, nuclear receptors, and other key proteins and enzymes).
• Synthesis automation (IRORI synthesis automation instrumentation).

For more information on ChemRx Chemistry services click here.

ChemRx also offers its Biology services for assay development and ultra high throughput screening. These services include:

• Assay development.
• High-throughput screening and lead identification.
• Lead optimization.
• ADME profiling.
• Safety profiling.
• High content screening.
• Biological production.

For more information on ChemRx Biology services click here.

ChemRx also offers its expertise in Computational discovery. These services include:

• Integrated drug design.
• Packaged solutions.
• Virtual screening and lead optimization.
• High-throughput screening experiment design and analysis.

For more information on ChemRx Computational discovery click here.

IRORI, another subsidiary of Discovery Partners International Inc. (DPII), offers its radio-frequency tagged product line for synthesis in drug discovery. For a review on IRORI's Accutag system here at CombiChem Lab click here.